Bluejay Diagnostics Inc(BJDX) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Oct 21 at 5:14 PM ET (Korea 10/22 06:14)
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -9.49 | Insider Own | 2.83% | Shs Outstand | 4.5M | Perf Week | -14.19% |
| Market Cap | 0.00B | Forward P/E | - | EPS next Y | - | Insider Trans | 263.44% | Shs Float | 4.3M | Perf Month | -32.43% |
| Enterprise Value | -0.01B | PEG | - | EPS next Q | - | Inst Own | 8.35% | Short Float | 3.31% | Perf Quarter | -40.73% |
| Income | -0.01B | P/S | - | EPS this Y | - | Inst Trans | 7.49% | Short Ratio | 0.05 | Perf Half Y | -66.21% |
| Sales | 0.00B | P/B | 0.14 | EPS next 5Y | - | ROA | -81.07% | Short Interest | 0.14M | Perf YTD | -74.68% |
| Book/sh | 4.75 | P/C | 0.31 | EPS past 3/5Y | 89.89% 65.04% | ROE | -98.89% | 52W High | -93.67% ($10.68) | Perf Year | -93.4% |
| Cash/sh | 2.15 | P/FCF | - | Sales past 3/5Y | - | ROIC | -77.21% | 52W Low | 1.59% ($0.67) | Perf 3Y | -99.99% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 93.91% | Gross Margin | - | Volatility(W/M) | 5.33% 6.76% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.06 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 4.64 | EPS Q/Q | 80.19% | Profit Margin | - | RSI (14) | 32.46 | Recom | 3 |
| Dividend Gr. 3/5Y | - | Current Ratio | 4.64 | Sales Q/Q | - | SMA20 | -17.13% ($0.82) | Beta | 0.89 | Target Price | $51200 |
| Payout | - | Debt/Eq | 0.01 | Earnings | 2026/8/13 | SMA50 | -23.46% ($0.89) | Rel Volume | 0.01 | Prev Close | $0.67 |
| Employees | 6 | LT Debt/Eq | 0 | EPS/Sales Surpr. | -155.21% - | SMA200 | -64.77% ($1.93) | Avg Volume(3M) | 3.14M | Price | $0.68 |
| IPO | 2021/11/10 | Option/Short | No/Yes | Trades | 159 | Volume | 31,446 | Change | 0.78% |
🔬 A point-of-care diagnostics company. Symphony biomarker platform. Rapid IL-6 test for sepsis. FDA approval in progress. Targeting $0M in funding for 2026.
Over the past 1 year, on the lower side
94% below its 1-year high.
Traded less than usual. That is 1% of its average volume.
BJDX has a sound balance sheet but weak earning power
Losses or thin margins. Early-stage growth or weakening competitiveness
Tap to view numbers
Results have missed expectations
Frequently misses analyst estimates
Tap to view numbers
Holding long would have lost money
Bought 3 years ago, your return today would be -100.0%.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Institutions barely hold it
Institutions hold 8.3%.
Tap to view numbers
It ranks #136 of 142 in the industry
Based on market cap of $3M.
ICCM#133 Icecure Medical Ltd $4M PER - 
AIDX#134 20/20 Biolabs Inc $3M PER - 
ADGM#135 Adagio Medical Holdings Inc $3M PER - BJDX#136 Bluejay Diagnostics Inc $3M PER - 
IVF#137 INVO Fertility Inc $3M PER - 
FAQ
What kind of company is BJDX?
BJDX belongs to the Healthcare sector and operates in the Medical Devices industry.
What is the market cap of BJDX?
The market cap of BJDX is approximately $3M, ranking 5,743 within its sector.
What is the 52-week high and low for BJDX?
BJDX has recorded a 52-week high of $10.68 and a low of $0.67.
